Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(22):1704-1711; doi:10.1093/jnci/94.22.1704
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hu, X.
Right arrow Articles by Cleary, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, X.
Right arrow Articles by Cleary, M. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 22, 1704-1711, November 20, 2002
© 2002 Oxford University Press


ARTICLE

Leptin—A Growth Factor in Normal and Malignant Breast Cells and for Normal Mammary Gland Development

Xin Hu, Subhash C. Juneja, Nita J. Maihle, Margot P. Cleary

Affiliations of authors: X. Hu, M. P. Cleary, The Hormel Institute, University of Minnesota, Austin; S. C. Juneja, N. J. Maihle, Departments of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.

Correspondence to: Margot P. Cleary, Ph.D., The Hormel Institute, University of Minnesota, 801 16th Ave. NE, Austin, MN 55912 (e-mail: mpcleary{at}hi.umn.edu).

Background: Obesity is a risk factor for breast cancer in postmenopausal women. As body weight and fat mass increase, circulating leptin increases. Leptin is an adipocyte-derived cytokine that acts through the long form of its receptor, termed OB-Rb. To investigate whether leptin is associated with breast cancer, we determined the expression of OB-Rb in human breast epithelial HBL100 cells and human breast carcinoma-derived T-47D cells, determined whether leptin influenced the proliferation of these cells, and evaluated the structure of mammary tissue in genetically obese leptin-deficient LepobLepob and leptin receptor-deficient LeprdbLeprdb mice. Methods: Cell numbers and cell colony formation by HBL100 and T-47D cells were determined by anchorage-dependent and anchorage-independent growth assays. OB-Rb expression was examined by reverse transcription–polymerase chain reaction and immunoblot analyses. Expression of leptin signaling pathway components was evaluated with immunoblot and electrophoretic mobility shift assays. Mammary gland development in lean and obese mice was investigated in whole-mount studies. All statistical tests were two-sided. Results: Leptin enhanced anchorage-dependent proliferation by 138% (95% confidence interval [CI] = 108% to 169%) in T-47D cells and 50% (95% CI = 38% to 60%) in HBL100 cells. In both cell lines, OB-Rb was expressed, and leptin increased the expression of phosphorylated signal transducers and activators of transcription 3 (STAT3), phosphorylated extracellular signal-regulated kinase (ERK), and transcript activator protein 1 (AP-1). However, leptin increased anchorage-independent cell growth only in the breast cancer cell line (by 81% [95% CI = 62% to 101%] compared with untreated cells). Obese LepobLepob and LeprdbLeprdb mice had minimal epithelial development in the mature mammary gland compared with their lean counterparts. Conclusions: Leptin appears to be able to control the proliferation of both normal and malignant breast epithelial cells. Consequently, the leptin pathway should be further studied as a target for interventions to treat or prevent breast cancer.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. P. Cleary and M. E. Grossmann
Obesity and Breast Cancer: The Estrogen Connection
Endocrinology, June 1, 2009; 150(6): 2537 - 2542.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Johansson, S. Gandini, A. Guerrieri-Gonzaga, S. Iodice, M. Ruscica, B. Bonanni, M. Gulisano, P. Magni, F. Formelli, and A. Decensi
Effect of Fenretinide and Low-Dose Tamoxifen on Insulin Sensitivity in Premenopausal Women at High Risk for Breast Cancer
Cancer Res., November 15, 2008; 68(22): 9512 - 9518.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. B. Peterson, Y. Huang, P. A. Newcomb, L. Titus-Ernstoff, A. Trentham-Dietz, G. Anic, and K. M. Egan
Childbearing Recency and Modifiers of Premenopausal Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3284 - 3287.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. N Perera, H. G Chin, N. Duru, and I. G Camarillo
Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression
J. Endocrinol., November 1, 2008; 199(2): 221 - 233.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
L. F. P. Silva, B. E. Etchebarne, M. S. Weber Nielsen, J. S. Liesman, M. Kiupel, and M. J. VandeHaar
Intramammary Infusion of Leptin Decreases Proliferation of Mammary Epithelial Cells in Prepubertal Heifers
J Dairy Sci, August 1, 2008; 91(8): 3034 - 3044.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
C M Friedenreich and A E Cust
Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects
Br. J. Sports Med., August 1, 2008; 42(8): 636 - 647.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. N. Perera, H. S. Spalding, S. I. Mohammed, and I. G. Camarillo
Identification of Proteins Secreted from Leptin Stimulated MCF-7 Breast Cancer Cells: A Dual Proteomic Approach
Experimental Biology and Medicine, June 1, 2008; 233(6): 708 - 720.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
L. Vona-Davis and D. P Rose
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Mauro, S. Catalano, G. Bossi, M. Pellegrino, I. Barone, S. Morales, C. Giordano, V. Bartella, I. Casaburi, and S. Ando
Evidences that Leptin Up-regulates E-Cadherin Expression in Breast Cancer: Effects on Tumor Growth and Progression
Cancer Res., April 1, 2007; 67(7): 3412 - 3421.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. P. Cleary, X. Hu, M. E. Grossmann, S. C. Juneja, S. Dogan, J. P. Grande, and N. J. Maihle
Prevention of Mammary Tumorigenesis by Intermittent Caloric Restriction: Does Caloric Intake During Refeeding Modulate the Response?
Experimental Biology and Medicine, January 1, 2007; 232(1): 70 - 80.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. M. Huffman, M. S. Johnson, A. Watts, A. Elgavish, I. A. Eltoum, and T. R. Nagy
Cancer Progression in the Transgenic Adenocarcinoma of Mouse Prostate Mouse Is Related to Energy Balance, Body Mass, and Body Composition, but not Food Intake
Cancer Res., January 1, 2007; 67(1): 417 - 424.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Wang, J. B. Lam, K. S.L. Lam, J. Liu, M. C. Lam, R. L.C. Hoo, D. Wu, G. J.S. Cooper, and A. Xu
Adiponectin Modulates the Glycogen Synthase Kinase-3{beta}/{beta}-Catenin Signaling Pathway and Attenuates Mammary Tumorigenesis of MDA-MB-231 Cells in Nude Mice
Cancer Res., December 1, 2006; 66(23): 11462 - 11470.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
D.-M. Alexe, G. Syridou, and E. Th. Petridou
Determinants of Early Life Leptin Levels and Later Life Degenerative Outcomes
Clin. Med. Res., December 1, 2006; 4(4): 326 - 335.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. J. Meyer, A. V. Capuco, D. A. Ross, L. M. Lintault, and M. E. Van Amburgh
Developmental and nutritional regulation of the prepubertal bovine mammary gland: II. Epithelial cell proliferation, parenchymal accretion rate, and allometric growth.
J Dairy Sci, November 1, 2006; 89(11): 4298 - 4304.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. R. Gonzalez, S. Cherfils, M. Escobar, J. H. Yoo, C. Carino, A. K. Styer, B. T. Sullivan, H. Sakamoto, A. Olawaiye, T. Serikawa, et al.
Leptin Signaling Promotes the Growth of Mammary Tumors and Increases the Expression of Vascular Endothelial Growth Factor (VEGF) and Its Receptor Type Two (VEGF-R2)
J. Biol. Chem., September 8, 2006; 281(36): 26320 - 26328.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Ablamunits, Y. Cohen, I. B. Brazee, H. P. Gaetz, C. Vinson, and S. Klebanov
Susceptibility to Induced and Spontaneous Carcinogenesis Is Increased in Fatless A-ZIP/F-1 but not in Obese ob/ob Mice.
Cancer Res., September 1, 2006; 66(17): 8897 - 8902.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A M Lorincz and S Sukumar
Molecular links between obesity and breast cancer.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 279 - 292.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D Sharma, N K Saxena, P M Vertino, and F A Anania
Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 629 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. de Assis, M. Wang, S. Goel, A. Foxworth, W. Helferich, and L. Hilakivi-Clarke
Excessive Weight Gain during Pregnancy Increases Carcinogen-Induced Mammary Tumorigenesis in Sprague-Dawley and Lean and Obese Zucker Rats
J. Nutr., April 1, 2006; 136(4): 998 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Revillion, M. Charlier, V. Lhotellier, L. Hornez, S. Giard, M.-C. Baranzelli, J. Djiane, and J.-P. Peyrat
Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers.
Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2088 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Garofalo, M. Koda, S. Cascio, M. Sulkowska, L. Kanczuga-Koda, J. Golaszewska, A. Russo, S. Sulkowski, and E. Surmacz
Increased Expression of Leptin and the Leptin Receptor as a Marker of Breast Cancer Progression: Possible Role of Obesity-Related Stimuli
Clin. Cancer Res., March 1, 2006; 12(5): 1447 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Malin, C. E. Matthews, X.-O. Shu, H. Cai, Q. Dai, F. Jin, Y.-T. Gao, and W. Zheng
Energy Balance and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1496 - 1501.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. J. Roth, D. N. Paltoo, P. S. Albert, D. J. Baer, J. T. Judd, J. Tangrea, and P. R. Taylor
Common Leptin Receptor Polymorphisms do not Modify the Effect of Alcohol Ingestion on Serum Leptin Levels in a Controlled Feeding and Alcohol Ingestion Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1576 - 1578.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Groschl, H-G Topf, J Kratzsch, J Dotsch, W Rascher, and M Rauh
Salivary leptin induces increased expression of growth factors in oral keratinocytes
J. Mol. Endocrinol., April 1, 2005; 34(2): 353 - 366.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. J. Fabian and B. F. Kimler
Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer
J. Clin. Oncol., March 10, 2005; 23(8): 1644 - 1655.
[Full Text] [PDF]


Home page
Endocr Relat CancerHome page
L Hilakivi-Clarke, C Wang, M Kalil, R Riggins, and R G Pestell
Nutritional modulation of the cell cycle and breast cancer
Endocr. Relat. Cancer, December 1, 2004; 11(4): 603 - 622.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Garofalo, D. Sisci, and E. Surmacz
Leptin Interferes with the Effects of the Antiestrogen ICI 182,780 in MCF-7 Breast Cancer Cells
Clin. Cancer Res., October 1, 2004; 10(19): 6466 - 6475.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. C. Russo, S. Metaxas, K. Kobayashi, M. Harris, and G. A. Werther
Antiapoptotic Effects of Leptin in Human Neuroblastoma Cells
Endocrinology, September 1, 2004; 145(9): 4103 - 4112.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Yin, D. Wang, H. Zhang, X. Yi, X. Sun, B. Shi, H. Wu, G. Wu, X. Wang, and Y. Shang
Molecular Mechanisms Involved in the Growth Stimulation of Breast Cancer Cells by Leptin
Cancer Res., August 15, 2004; 64(16): 5870 - 5875.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. P. Nunez, D. Jelovac, L. Macedo, D. Berrigan, S. N. Perkins, S. D. Hursting, J. C. Barrett, and A. Brodie
Effects of the Antiestrogen Tamoxifen and the Aromatase Inhibitor Letrozole on Serum Hormones and Bone Characteristics in a Preclinical Tumor Model for Breast Cancer
Clin. Cancer Res., August 15, 2004; 10(16): 5375 - 5380.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
C. Farmer, D. Petitclerc, M. T. Sorensen, M. Vignola, and J. Y. Dourmad
Impacts of dietary protein level and feed restriction during prepuberty on mammogenesis in gilts
J Anim Sci, August 1, 2004; 82(8): 2343 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Ishikawa, J. Kitayama, and H. Nagawa
Enhanced Expression of Leptin and Leptin Receptor (OB-R) in Human Breast Cancer
Clin. Cancer Res., July 1, 2004; 10(13): 4325 - 4331.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Ross
Looking Farther Afield
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 906 - 907.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Catalano, L. Mauro, S. Marsico, C. Giordano, P. Rizza, V. Rago, D. Montanaro, M. Maggiolini, M. L. Panno, and S. Ando
Leptin Induces, via ERK1/ERK2 Signal, Functional Activation of Estrogen Receptor {alpha} in MCF-7 Cells
J. Biol. Chem., May 7, 2004; 279(19): 19908 - 19915.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Hirose, K. Hata, T. Kuno, K. Yoshida, K. Sakata, Y. Yamada, T. Tanaka, B. S. Reddy, and H. Mori
Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice
Carcinogenesis, May 1, 2004; 25(5): 821 - 825.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. P. Cleary, S. C. Juneja, F. C. Phillips, X. Hu, J. P. Grande, and N. J. Maihle
Leptin Receptor-Deficient MMTV-TGF-{alpha}/LeprdbLeprdb Female Mice Do Not Develop Oncogene-Induced Mammary Tumors
Experimental Biology and Medicine, February 1, 2004; 229(2): 182 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. A. Masso-Welch, D. Zangani, C. Ip, M. M. Vaughan, S. F. Shoemaker, S. O. McGee, and M. M. Ip
Isomers of Conjugated Linoleic Acid Differ in Their Effects on Angiogenesis and Survival of Mouse Mammary Adipose Vasculature
J. Nutr., February 1, 2004; 134(2): 299 - 307.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Eng-Wong, S. D. Hursting, D. Venzon, S. N. Perkins, and J. A. Zujewski
Effect of Raloxifene on Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Leptin in Premenopausal Women at High Risk for Developing Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1468 - 1473.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. J. Roth, D. J. Baer, P. S. Albert, T. W. Castonguay, J. F. Dorgan, S. M. Dawsey, E. D. Brown, T. J. Hartman, W. S. Campbell, C. A. Giffen, et al.
Relationship Between Serum Leptin Levels and Alcohol Consumption in a Controlled Feeding and Alcohol Ingestion Study
J Natl Cancer Inst, November 19, 2003; 95(22): 1722 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Miyoshi, T. Funahashi, S. Kihara, T. Taguchi, Y. Tamaki, Y. Matsuzawa, and S. Noguchi
Association of Serum Adiponectin Levels with Breast Cancer Risk
Clin. Cancer Res., November 15, 2003; 9(15): 5699 - 5704.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Oelmann, S. Haghgu, E. Kulimova, H. Serve, C. Schmitmann, and W. E. Berdel
Re: Leptin--A Growth Factor in Normal and Malignant Breast Cells and for Normal Mammary Gland Development
J Natl Cancer Inst, August 6, 2003; 95(15): 1171 - 1173.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza, M. L. Panno, and S. Ando
Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line
J. Biol. Chem., August 1, 2003; 278(31): 28668 - 28676.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.